Allogene Therapeutics, Inc.: Allogene Therapeutics Announces Benjamin M. Beneski as Senior ...
Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR ...
Allogene Therapeutics Announces Benjamin M. Beneski as Senior Vice President and Chief ...
SOUTH SAN FRANCISCO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ALLO), a clinical-stage biotechnology company ...